Expression of Glypican-3 (GPC3) in breast cancer tumors from Brazilian and Argentinean patients

被引：0
|
作者：
Lago Huvelle, Maria A. [1 ]
Maia, Aline [2 ]
Fujita, Andre [3 ]
Armanasco, Eduardo [4 ]
Bagnoli, Fabio [5 ]
de Oliveira, Vilmar Marques [5 ]
Longo Galvao Silva, Maria A. [5 ]
de Kier Joffe, Elisa Bal [1 ]
Sogayar, Mari C. [2 ]
Puricelli, Lydia [1 ]
Labriola, Leticia [2 ]
Peters, Maria G. [1 ]
机构：
[1] Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Matemat & Estat, Dept Ciencia Comp, Sao Paulo, Brazil
[4] Inst Oncol Angel H Roffo, Dept Surg, Buenos Aires, DF, Argentina
[5] Hosp Irmandade Snata Casa de Misericordia Sao Pau, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
448
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation
    Guereno, Macarena
    Delgado Pastore, Magali
    Clara Lugones, Ana
    Cercato, Magali
    Todaro, Laura
    Urtreger, Alejandro
    Giselle Peters, Maria
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2020, 99 (06)
  • [22] Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
    Yasuda, Eisuke
    Kumada, Takashi
    Toyoda, Hidenori
    Kaneoka, Yuji
    Maeda, Atsuyuki
    Okuda, Seiji
    Yoshimi, Naoki
    Kozawa, Osamu
    HEPATOLOGY RESEARCH, 2010, 40 (05) : 477 - 485
  • [23] The Expression of Glypican-3 in Colorectal Cancer
    Azizpour, Sonia
    Ezati, Razieh
    Saidijam, Massoud
    Razavi, Amirnader Emami
    Jalilian, Farid Azizi
    Mahdavinezhad, Ali
    Eslami, Hamid
    Soltanian, Alireza
    Mohammadpour, Hadiseh
    Kamali, Fatemeh
    Amini, Razieh
    CYTOLOGY AND GENETICS, 2019, 53 (05) : 430 - 440
  • [24] The Expression of Glypican-3 in Colorectal Cancer
    Sonia Azizpour
    Razieh Ezati
    Massoud Saidijam
    Amirnader Emami Razavi
    Farid Azizi Jalilian
    Ali Mahdavinezhad
    Hamid Eslami
    Alireza Soltanian
    Hadiseh Mohammadpour
    Fatemeh Kamali
    Razieh Amini
    Cytology and Genetics, 2019, 53 : 430 - 440
  • [25] Zoledronate induce expansion of glypican-3 (GPC3) peptide specific cytotoxic T ILymphocytes sufficient for adoptive cancer immunotherapy
    Yoshikawa, Toshiaki
    Takahara, Masashi
    Tomiyama, Mai
    Kuroda, Ayumi
    Shirakawa, Hirofumi
    Nobuoka, Daisuke
    Sawada, Yu
    Sakemura, Noriko
    Nieda, Mie
    Maekawa, Ryuji
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2012, 72
  • [26] Glypican-3 (GPC3) inhibits the metastasis development in a murine breast cancer model through the activation of p38MAPK signaling pathway
    Tascon, Rocio S.
    Castillo, Lilian
    de Kier Joffe, Elisa Bal
    Peters, Maria G.
    CANCER RESEARCH, 2015, 75
  • [27] Somatic glypican 3 (GPC3) mutations in Wilms' tumour
    White, GRM
    Kelsey, AM
    Varley, JM
    Birch, JM
    BRITISH JOURNAL OF CANCER, 2002, 86 (12) : 1920 - 1922
  • [28] Somatic glypican 3 (GPC3) mutations in Wilms' tumour
    G R M White
    A M Kelsey
    J M Varley
    J M Birch
    British Journal of Cancer, 2002, 86 : 1920 - 1922
  • [29] Glypican-3 (GPC3) modulates Wnt, Akt and p38 signaling pathways in a murine mammary adenocarcinoma
    Giselle Peters, Maria
    Stigliano, Ivan D.
    Peluffo, Guillermo D.
    Vazquez, Paula
    Puricelli, Lydia I.
    de Kier Joffe, Elisa D. Bal
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Activation status and function of the canonical Wnt pathway in murine mammary tumor cells reexpressing Glypican-3 (GPC3)
    Lago Huvelle, Maria A.
    Romero, Silvina A.
    Castillo, Lilian
    de Kier Joffe, Elisa Bal
    Peters, Maria G.
    CANCER RESEARCH, 2012, 72
12345